For over 12 years, dQ&A has gathered primary data from diabetes healthcare practitioners (HCPs)—notably endocrinologists and primary care physicians—expanding our ‘Prescriber Perspectives’ tracker to five countries with insights from key prescribers and influencers.
We partnered with LMC to connect real-world patient experience insights with validated clinical data for patients across the diabetes spectrum.
Our survey of 190 U.S. endocrinologists finds GLP-1 and SGLT2 prescribing at 90%+ and rising, while many patients resist starting basal insulin.
A dQ&A-CeQur study in Clinical Diabetes finds 2 months on the CeQur Simplicity insulin patch boosts patient satisfaction, cuts burden, and lifts well-being.
This article reports results of a survey of patients and health care providers regarding their experiences of and challenges with the use of basal insulin.
dQ&A research reveals primary care challenges in adopting diabetes tech, highlighting needs for CGM training, simpler tools, and better industry support.
Our research finds Mounjaro patients report health benefits but face confusion and frustration during therapy initiation.
Our European study explores Time in Range in diabetes, comparing outcomes and differences across six countries.
Philly De Piante recently presented dQ&A data on Advances in Disease-Modifying Interventions at the Global Congress on Cardiology. Watch the video here.
